Trinity Biotech (TRIB) Assets Average (2009 - 2025)

Trinity Biotech has disclosed Assets Average across 17 years of filings, most recently posting $102.4 million for Q4 2025.

• Assets Average for Q4 2025 came in at $102.4 million, up 2.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $102.4 million (up 2.02% YoY), and the FY2025 annual result was $104.2 million, up 28.1% from the prior year.
• Assets Average came in at $102.4 million for Q4 2025 at Trinity Biotech, up from $101.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $133.2 million in Q1 2021 to a low of $61.5 million in Q4 2023.
• The 5-year median for Assets Average is $100.9 million (2024), against an average of $99.7 million.
• Across the five-year window, Assets Average tumbled 35.25% in 2023 and soared 63.16% in 2024, its largest moves.
• Trinity Biotech's Assets Average stood at $120.8 million in 2021, then dropped by 21.38% to $95.0 million in 2022, then slumped by 35.25% to $61.5 million in 2023, then soared by 63.16% to $100.4 million in 2024, then rose by 2.02% to $102.4 million in 2025.
• The last three Assets Average figures came in at $102.4 million (Q4 2025), $101.5 million (Q2 2025), and $100.4 million (Q4 2024), per Business Quant data.